In using bioinformatic tools, a study identifies the mechanisms of kidney injury and cancer that correlate with exposure to ...
The 1.34 mg dose of Fotivda shows greater antitumor activity than the 0.89 mg dose in RCC patients, with similar hypertension incidence. Higher Fotivda exposure correlates with improved ...
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting. Among patients who have received immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback